
Last updated: 9 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience
Stem cell treatment in India attracts many patients with inherited and degenerative eye disease, especially those who have been told that conventional options are exhausted. India has experienced doctors and lower costs, but eye procedures also carry high stakes. This guide explains what is approved, what is investigational, how medical travel works and how to verify any provider before you commit.
Quick Navigation
“Stem cell treatment” describes very different things. Blood stem cell transplants are established for conditions such as leukemia and thalassemia. For eye disease, most stem cell use is investigational, including approaches for retinitis pigmentosa, optic nerve atrophy and macular degeneration. Corneal surface repair with limbal stem cells is a recognised exception performed by corneal specialists.
| Category | Status | What it involves |
|---|---|---|
| Corneal limbal stem cell transplantation | Established for selected corneal surface disease | Performed by corneal surgeons at specialist centres |
| Blood stem cell transplantation (HSCT) | Established for approved indications | Blood cancers, thalassemia and some inherited disorders |
| Stem cell therapy for retinal and optic nerve disease | Investigational. Permitted only within approved clinical research | Studies on protecting or replacing retinal and nerve cells |
Patients travel from many countries for care. Plan ahead:
Indian regulators distinguish between established treatments and research. Hematopoietic stem cell transplantation for approved indications is standard care; other uses are investigational under the National Guidelines for Stem Cell Research, 2017. The September 2026 advisory on regulation of stem cell therapy from the Ministry of Health and Family Welfare confirms that routine clinical use is limited to approved indications.
Always check the current position on the official sources at the end of this article.
Procedures involving the eye or optic nerve can cause infection, bleeding, raised eye pressure, retinal detachment and, in the worst cases, permanent loss of remaining vision. Serious harm has been reported after unregulated stem cell injections into the eye. Only agree to a procedure that is part of an approved protocol, performed by a qualified eye surgeon, with ethics committee approval and written informed consent. Always keep your own eye specialist informed, and do not stop current treatment on your own.
Because treatment plans differ widely, no honest provider can quote one fixed price in advance of assessment. Ask what the estimate covers (tests, procedure, hospital stay, follow-up), who pays if a complication occurs, and get everything in writing before you travel.
Yes, within the regulatory framework. HSCT for approved indications is standard care; other use is investigational and permitted under national guidelines.
Not as routine treatment, apart from established procedures such as limbal stem cell transplantation.
No. Be cautious of anyone who claims to cure blindness or restore vision.
Your diagnosis, eye scans (such as OCT), ERG and field reports and recent clinic notes.
It depends on the plan; ask for the schedule and follow-up arrangements in writing before travelling.
Stem cell treatment in India offers access to experienced doctors, but for eye disease it is largely investigational. Verify approvals, ask for documents and keep your own specialist involved.
You can read about stem cell therapy in India, retinitis pigmentosa treatment in India and retinal dystrophy disease treatment in India, or upload your reports and contact our team to discuss your options.

